FDA Inspection 1209127 — Novo Nordisk A/S
The FDA completed an inspection of Novo Nordisk A/S on May 4, 2023 in Kalundborg. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- May 4, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Kalundborg (Denmark)